Legal basis and governing authority
- Section 40 of Republic Act No. 6425 (as amended) is the legal basis for issuing the prohibited-drugs list.
- The regulation establishes a list of prohibited drugs specifically pursuant to Section 40, Republic Act No. 6425, as amended.
- The regulation’s coverage is organized by drug classes, including Opiates, Cocaine, Cannabis, and Hallucinogenics.
- The regulation provides named drug items and formulations as prohibited drugs, including trade names.
Policy and intent statement
- The regulation is issued for the information of the general public.
- The regulation provides a publicly identifiable list of prohibited drugs to aid compliance with Republic Act No. 6425.
- The regulation organizes drugs by pharmacological type and includes specific forms, derivatives, and preparations.
Core definitions and classification rules
- The regulation defines Cocaine to include:
- Coca leaf preparations containing more than 0.1 per cent of cocaine and made direct from coca leaf;
- Cocaine (methyl ester of benzoylecgonine);
- Ecgonine, including its esters and derivatives which are convertible to ecgonine and cocaine.
- The regulation defines Cannabis (Indian Hemp) through drug forms:
- Marijuana plant covers dried flowering or fruiting of pestillate cannabis plant from which the resin has not been extracted; and also the flowering or fruiting tops of the cannabis plant, fresh or dried.
- Cannabis resin covers the separated resin, whether crude or purified, obtained from the cannabis plant, including Hashish, Tetrahydrocannabinol (THC), and tincture and extracts.
- Marijuana cigarettes or reefers are included as a distinct category under Cannabis.
- The regulation treats listed hallucinogenic entries as prohibited hallucinogenics by specific name and abbreviation.
Coverage: prohibited drugs list
- The regulation lists prohibited drugs in the following major categories:
- I. Opiates
- II. Cocaine
- III. Cannabis
- IV. Hallucinogenics
- V. Alfa and Beta Eucaine
- The regulation includes both base substances and specific preparations/forms (including extracts, tinctures, intermediates, derivatives, and products).
- The regulation expressly recognizes extensive named derivatives and trade-name variants for multiple opiates and synthetics.
Prohibited opiates: forms, thresholds, derivatives
- Under Opiates, Opium in the following forms is prohibited, including:
- Medicinal opium: opium in any form, whether mixed with a neutral substance or not, which has undergone the process necessary to adapt it for medicinal use;
- Raw opium, including non-medical powdered and granulated forms;
- Opium tinctures and extracts containing more than 0.2% of anhydrous morphine.
- Under Opiates, Opium, other is prohibited, including:
- Prepared for smoking;
- Doss;
- Charred;
- Poppy straw.
- Under Opiates, Opium-Alkaloids and Derivatives are prohibited, including:
- Alkaloids: Morphine, Thebaine, Codeine-Methyl morphine.
- Derivatives, including the explicitly enumerated derivatives and their listed names and code/trade names, such as:
- Acetorphine M183, BENZYLMORPHINE, CODOXINE, CONCENTRATE OF POPPY STRAW, DESOMORPHINE-Dihydrod desoxymorphine; Sco-permid IDaCcS, DEXTROMORAMIDE, and other listed derivatives.
- HEROIN (with listed names Acetomorphine, Diaphorm, Diacetylmorphine, Eclorion, Diamorphine).
- HYDROCODONE and its listed variants (including Ambenyl, Hubacodid, Assicodid, Hycodan, Biatos, Hydrocodin, Biocodone, Hydrokon, Broncodid, Kolikodal, Calmodid, Mercodol, Codesona, and others listed).
- HYDROMORPHINOL, HYDROMORPHONE, and all listed variants (including Assilaudid, Laudacon, Biomorphyl, Laudadin, Cofalaudide, Laudamed, and others listed).
- LEVOPHENACYLMORPHAN, METHYLDESORPHINE, METHYLDIHYDROMORPHINE, METOPON, MORPHINE N-OXIDE, MYROPHINE, NICODICODINE, NICOMORPHINE, NORMORPHINE, OXYCODONE, OXYMORPHONE, PHENOMORPHAN, RACEMETHORPHAN, RACEMORPHAN, and THEBACON.
- Under Opiates, additional opiate alkaloids/entries listed as prohibited include:
- ACETYLDIHYDROCODEINE, DIHYDROCODEINE, ETHYLMORPHINE, NICOCODINE, NORCODEINE, and PHOLCODINE.
- Under Opiates, synthetics and others having similar physiological effects as Narcotic drugs is prohibited and includes the enumerated synthetics, intermediates, and related compounds, such as FENTANYL, METHADON INTERMEDIATE, MORAMIDE INTERMEDIATE, METHADON, PETHIDINE, and other listed entries with their listed names.
Prohibited cocaine
- Cocaine is prohibited and includes coca leaf preparations containing more than 0.1 per cent of cocaine made direct from coca leaf.
- Cocaine is prohibited as cocaine (methyl ester of benzoylecgonine).
- Cocaine is also prohibited as ecgonine, including its esters and derivatives that are convertible to ecgonine and cocaine.
Prohibited cannabis forms
- Cannabis (Indian Hemp) Cannabis Sativa L. is prohibited through its enumerated forms:
- Marijuana plant as dried flowering or fruiting of the pestillate plant from which resin has not been extracted, and the flowering/fruiting tops whether fresh or dried.
- Cannabis resin, including hashish, tetrahydrocannabinol (THC), and tincture and extracts.
- Marijuana cigarettes or reefers.
Prohibited hallucinogenics
- Hallucinogenics are prohibited and include the enumerated substances by name and abbreviation, including:
- DET, DMHP, DMT, LSD (including LSD-25 and (+)-N,N-diethyllysergamide),
- Mesacaline, Psilocine/psilotsin, Psilocybine,
- SPT/DOM, Bufotenine, Ibogaine, Peyote, and Morning Glory Creeper.
- The regulation treats each enumerated hallucinogen as a prohibited drug entry.
Guidance on trade names and completeness
- The regulation states that the list of trade names does not purport to be exhaustive.
- The regulation states that the absence of the name of a preparation containing a narcotic, synthetic, or hallucinogenic drug does not necessarily mean that the preparation is not under control.
- The regulation includes extensive trade-name lists under multiple opiate and synthetic entries to guide identification.
Issuance details and adoption
- The regulation is adopted on 4 Dec. 1972.
- The regulation is signed by CLEMENTE S. GATMAITAN, M.D., M.P.H. as Chairman.
- The regulation is numbered as DDB Board Regulation No. 5 s. 1972 and focuses on a prohibited-drugs list under Section 40, Republic Act No. 6425, as amended.